Antiviral Drug Remdesivir: The Relationship Between Patent Protection And Right to Health

Must Read

What is the Real Estate (Regulation and Development) Act, 2016?

The Real Estate (Regulation and Development) Act, 2016 (“RERA”) is an Act of the Parliament. It seeks to protect...

Should the Exorbitant Amounts Charged for RT-PCR Tests be Refunded?

Introduction A plea has been filed in the Honourable Supreme Court of India seeking a refund of exorbitant amounts charged...

Should CCTV’s be Installed in the Police Station?

Introduction In a recent judgment, the bench led by Justice Nariman issued directions to both the state and Union Territory...

A Legal Analysis of the West Bengal Political Crisis on IPS Deputation

The Ministry of Home Affairs (MHA) has recently summoned three IPS officers of West Bengal (WB). The decision was...

Explained: Postal Ballot for NRIs

At the end of November 2020, Election Commission sent a proposal to the law ministry to amend the Representation...

Explained: Constitutional Provisions and Legislations With Regards to a Person with Disabilities

The world celebrates December 3 as International Day of Persons with Disabilities (IDPD). This day is also called World...

Follow us

The COVID-19 surge is getting worse. The Union Health Ministry, via its revised Protocol, has recommended Remdesivir. This is an antiviral drug that is a possibly effective treatment for COVID-19. The greatest tussle is always between affordability and accessibility. Should the public Health get priority over patent protection in the present scenario? Since Remdesivir is an effective treatment against COVID-19, should its patent be revoked? 

Understanding the Issue

On April 9, 2020, the Cancer Patients Aid Association wrote a letter to the Union Health Ministry. In it, they demanded patent revocation for Remdesivir. The application claimed revocation on the grounds of public interest under Section 66 of the Patents Act, 1970. The application stated that the patent lacks novelty and an inventive step. Both are grounds for post-grant opposition. The previous judgments which invoked Section 66 were on different grounds. One was that the patent was prejudicial to farmers’ rights. Another was that it formed a part of traditional knowledge.

Revoking Remdesivir patent could enervate the patent framework in India. Possible alternatives to the revocation are compulsory licensing and a patent pool. Compulsory licensing has worked well in Italy. Nevertheless, four pharma companies have signed voluntary licensing agreements with Gilead Sciences. Gilead Sciences Inc. is the original drug manufacturer for Remdesivir.  This trend suggests that India does not want to indulge in unnecessary politics. 

Why Remdesivir?

The fight over patent ownership gets intensified if one looks at the Cell Research Paper. This paper has suggested Remdesivir as an effective drug against COVID-19. Seven scientists from Wuhan and three from Beijing are responsible for writing it. Wuhan Institute of Virology has also applied for a patent for Remdesivir. This application was on the basis of second medical use. Chinese Patent law permits this kind of use. Criticising this tussle is not the way out because Remdesivir was a public-funded drug. 

Further, Sanofi’s Plaquenil (earlier used for SARS) has also treated a Japanese patient. Other drugs have also proved useful. However, no drug is a sure treatment against COVID-19. In such a scenario, should grant of a patent be prioritised over public health?

Nevertheless, if patentability is not that important, will COVID-19 render patent law sterile? The best possible alternative is to pay heed to public Health. Even so, patent protection is also necessary. 

Compulsory Licensing: An Alternative to Section 66

Compulsory licensing has proven to be an alternative to revocation of patents. The revocation of patents could be susceptible to controversies. Italy has adopted a compulsory licensing model. With fixation of a reasonable royalty, compulsory licensing can bring the required equilibrium. At this stage, where public Health is of exemplary importance, this model can take care of the clash. Countries like Israel and Ecuador have also implemented this model.

With a stark rise in demand, the affordability of medicines is another challenge. The public health criterion makes it essential to make drugs affordable. This alternative is best for countries which are cash-stripped. In Indian Patent Law, a precondition to this is a government notification.  At times, due to political pressures, governments are not in a position to grant these. 

Does India have Requisite Know- How?

Certain technical limitations exist with breaking patents. Extensive know-how is a prerequisite when it comes to patents. Where public health is at stake, Sections 92, 101, and 103 should be exercised with caution. For medical technologies, it may be a hassle. India’s pharmaceutical know-how is quite weighty. Bulk procurement and technology transfer agreements could also be helpful. 

Right to Health (Rth) Framework for Patent Policy

Access to medical aid is well within the realms of Right to Health under Article 21 of the Constitution. The Government also has positive obligations towards securing RtH of the patients. Provisions of masks, sanitisers, hazmat suits all fall under its duty, especially in cases of non-affordability or unavailability. Securing public Health at the cost of patent infringement could be fine. However, the reverse could render patent law hollow. 

This approach is also enshrined in General Comment No. 14 of ICESCR. Paragraph 37 of the comment notes that state parties should take positive steps. These steps should be towards securing the Right to Health. Moreover, this framework should be the basis for patent law. As innovation is of no use unless put to public usage.

Patent Pooling

Costa Rica had suggested patent pooling on the pillars of solidarity and collaboration. Unbiased access to medicines and other COVID-19 related technology is of utmost importance. Patent pooling will create a platform for pooling data. It will also pool knowledge, and patents to deliver health goods. To ensure affordability and accessibility, this information will be accessible to all. Patent pooling can act as a game-changer. It could bring in efficiency and improve collaboration. It will also help lessen transactional costs. The voluntary nature of patent pooling enables governments to give incentives. These may be tax breaks and providing R& D support to companies. In these times, pharma companies should develop a collaborative aptitude. 

Due to accessibility concerns, patients have also started importing Remdesivir from Bangladesh. Bangladesh can manufacture the same due to its exemption from TRIPS. The Drugs Controller General of India is still awaiting test results. Post this, they will issue approval to the Bangladeshi companies. 

However, the affordability concerns cannot abate by importing at individual levels. Right to Health is a fundamental right and available to all. The RtH framework is a must in these trying times.

 According to Ms Harshada Wadkar, a Senior Associate at Lex Orbis:

“Due to the global pandemic, the Government enforced a countrywide lockdown in March. Since then, IP offices are functioning remotely. Notices for extension are also issued. Along with the extension of deadlines, policy guidelines are also required. Fast-tracking of applications providing a particular solution can also be inspiring.” 

 Accordingly, practical measures and the RtH framework will strengthen the patent fabric. 

Conclusion and Recommendations

The pandemic has resulted in patent battles. Concerns of patent protection while ensuring public Health have increased. As the virus spreads, countries facing a financial crunch must look for alternatives. Patent law would remain hollow if not used for public welfare. The Right to Health framework is the best patent policy. 

Patent pooling through international collaboration can also prove to be useful. PPP patent pooling is also an effective way. Doha Declaration under TRIPS promotes patent pooling Also, Seagate technology has signed a Pledge. This Pledge is the Open COVID Pledge. Under this, it provides free access to its patent technology for diagnosis. Seagate has also announced the’Data4Good’ program. This enables employees to contribute their skills and expertise.

Another plausible solution could be a patent buy out. This is when the Government acquires the patent and gives it out in the public domain. A system of auction can help reach a fair price. The Government pays the highest bid. Also, a mark-up will incentivise the technology for a social cause. Patent experts are also required to figure out the authenticated patents. This will avoid low-quality patents.

 This way, patents can get secured without any compromise on public Health.


Libertatem.in is now on Telegram. Follow us for regular legal updates and judgements from the court. Follow us on Google News, InstagramLinkedInFacebook & Twitter. You can also subscribe for our Weekly Email Updates. You can also contribute stories like this and help us spread awareness for a better society. Submit Your Post Now.

Latest News

Parents of Road Accident Victim Entitled To Compensation: Delhi High Court

Justice JR Midha said, “Even if parents are not dependent on their children at the time of an accident, they will certainly be dependent, both financially and emotionally, upon them at the later stage of their life, as the children were dependent upon their parents in their initial years.”

Plea Challenging the AIBE Rules Framed by BCI Filed in the Supreme Court

A Writ Petition was presently filed in the Supreme Court by a newly enrolled lawyer challenging the All India Bar Examination Rules 2010 which have been framed by the Bar Council of India which mandates that an advocate has to qualify for the All India Bar Examination (AIBE) to practice law after enrollment.

Bombay High Court: Mere Presence at the Crime Scene Not Enough for Punishment

The Bombay High Court ruled that it cannot be considered a crime if a person is merely present at the crime scene which falls under the Maharashtra Prohibition of Obscene Dance in Hotels and Restaurants and Bar Rooms and Protection of Dignity of Women Act 2016. It also quashed two First Information Reports (FIR) against two individuals who were arrested in a raid at a dance bar by the Santacruz Police, in 2017.

CAIT Files a Plea Against WhatsApp’s New Privacy Policy in the Supreme Court

Confederation of All India Traders (CAIT) has filed a petition against WhatsApp’s new privacy rules in the Supreme Court. The petition says that WhatsApp which is known to render public services by providing a platform to communicate has recently imposed a privacy policy that is unconstitutional, which not only goes against the fundamental rights of citizens but also jeopardizes the national security of our country.

RTI Activist Files a Plea in Bombay High Court Against Bharat Biotech’s Covaxin

On Saturday, a plea has been filed before the Bombay High Court by an activist stating that Bharat Biotech Covaxin had not been granted full approval but a restricted use in clinical trials according to the Drugs Comptroller General of India. The Company's phase 3 trials are ongoing and the DGCI has not made any data available in the public domain for peer- review by independent scientists.

WhatsApp Emails Delhi HC Judge Asking Her Not To Hear the Plea Challenging New Privacy Policy

The Delhi High Court raised strong objection to an E-mail sent by WhatsApp asking a judge not to hear the plea which challenges its new privacy policy. Justice Pratibha Singh said that the e-mail that was withdrawn later was totally unwarranted as she was anyway going to recuse from hearing the plea which was filed by Rohilla Chaitanya who contends that the new privacy policy of WhatsApp provides 360-degree access to a customer’s virtual activity and is against the fundamental right of privacy.

TRP Scam Case: Bombay HC Extends Protection To Arnab Goswami and Other Employees Till the Next Hearing

On Friday, the Bombay High court extended the protection that was given, to Republic TV’s Editor in Chief Arnab Goswami and other employees of ARG Outlier Media Private Limited till January 29th in the alleged case of Television Rating Point manipulation. A status report was submitted by the police to the division bench of Justices S.S.Shinde and Manish Pitale by the Police on the ongoing case.

Plea Seeks FIR Against Maharashtra Minister Dhananjay Munde in Bombay HC for False Info

A plea has been filed in Bombay High Court seeking an FIR against Maharashtra minister Dhananjay Munde who is undergoing times of trouble due to his extra-marital affair. Recently, an FIR had been lodged against Munde by a woman, accusing him of raping her sister. Munde clarified that he was actually in a relationship with that woman and had two children. He accused the two women of blackmailing him.

Writ Petition for Compensation Accepted by Calcutta High Court 

Introduction The Petitioner Purna Ch. Biswas filed a Writ Petition with the complaint that their claims for a higher quantum of compensation have not yet...

No Members Could Be Disqualified Without Authorisation by Political Party: Gujarat High Court

Excerpt The dispute application no.7 of 2020 filed by respondent no.2 before designated authority. Thereafter the designated authority order dated 28.10.2020 disqualified the petitioner and...

More Articles Like This

- Advertisement -